Acinetobacter News and Research

RSS
Aradigm receives QIDP designation for its inhaled antibiotic candidate, Pulmaquin

Aradigm receives QIDP designation for its inhaled antibiotic candidate, Pulmaquin

New drug is effective against superbug MRSA

New drug is effective against superbug MRSA

Seward highlights effectiveness of Stomacher technique and sponge swabs for hygiene monitoring

Seward highlights effectiveness of Stomacher technique and sponge swabs for hygiene monitoring

FOB Synthesis enters into license agreement with AstraZeneca to treat drug-resistant bacterial infections

FOB Synthesis enters into license agreement with AstraZeneca to treat drug-resistant bacterial infections

Hot water contamination in hospital taps threatens patient safety

Hot water contamination in hospital taps threatens patient safety

Synthetic Biologics prices underwritten public offering of common stock at $1.00 per share

Synthetic Biologics prices underwritten public offering of common stock at $1.00 per share

Researchers identify resistance protein that allows bacteria to survive chlorhexidine

Researchers identify resistance protein that allows bacteria to survive chlorhexidine

New type of antibiotic kills multidrug-resistant germ common to health care settings

New type of antibiotic kills multidrug-resistant germ common to health care settings

FDA promise to "reboot" antibiotic development rules to combat rise in resistance falls short

FDA promise to "reboot" antibiotic development rules to combat rise in resistance falls short

Study reveals that Hudson River polluted with antibiotic-resistant bacteria

Study reveals that Hudson River polluted with antibiotic-resistant bacteria

BioFire Diagnostics' FilmArray Blood Culture Identification Panel receives FDA clearance

BioFire Diagnostics' FilmArray Blood Culture Identification Panel receives FDA clearance

Scientists find way to attack dangerous bacteria that cause eye infections

Scientists find way to attack dangerous bacteria that cause eye infections

Cubist receives Fast Track designation from FDA for late-stage antibiotic candidate

Cubist receives Fast Track designation from FDA for late-stage antibiotic candidate

Study confirms effectiveness of UV-C-emitting device in combating pathogens in hospital environment

Study confirms effectiveness of UV-C-emitting device in combating pathogens in hospital environment

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Xellia to develop new antibiotics effective against multi-drug resistant Gram-negative bacteria

Xellia to develop new antibiotics effective against multi-drug resistant Gram-negative bacteria

FDA designates two of Cubist’s Phase 3 antibiotic candidates

FDA designates two of Cubist’s Phase 3 antibiotic candidates

Current hospital cleaning protocol may be inadequate to rid MDR A. baumannii

Current hospital cleaning protocol may be inadequate to rid MDR A. baumannii

WellStar Health System implements Xenex’s room disinfection system

WellStar Health System implements Xenex’s room disinfection system

Metalloacid surfaces may be answer to hospital-acquired infections

Metalloacid surfaces may be answer to hospital-acquired infections